Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
10.1111/j.1469-8137.2006.01643.x 114 SairamK.RaoK
Reconstitute 3.0 mL BAC water Concentration 26.7 mg/mL total blend 1 unit (0.01 mL) ~267 mcg total blend Typical cycle 4-6 weeks Dose selector Component Delivery by Titration Step GHK-Cu:~1.25 mg KPV:~250 mcg BPC-157:~250 mcg TB-500:~250 mcg Selector options mirror the representative titration table above
Key takeaways Animal studies show BPC-157 improves gastric motility and protects against gastric damage in rats No human clinical trial has tested BPC-157 for gastroparesis specifically BPC-157 modulates the nitric oxide system and may interact with vagal nerve function, both relevant to gastroparesis Oral administration (250-500 mcg daily) is preferred over injection for GI-targeted effects BPC-157 is unusually stable in stomach acid, making oral delivery viable Patients should work with their gastroenterologist before adding BPC-157 to their gastroparesis management What is gastroparesis and why is it hard to treat
Coleman, M
